TD ASSET MANAGEMENT INC - IMMUNOGEN INC ownership

IMMUNOGEN INC's ticker is IMGN and the CUSIP is 45253H101. A total of 202 filers reported holding IMMUNOGEN INC in Q4 2017. The put-call ratio across all filers is 0.60 and the average weighting 0.0%.

Quarter-by-quarter ownership
TD ASSET MANAGEMENT INC ownership history of IMMUNOGEN INC
ValueSharesWeighting
Q3 2023$4,481,688
+142.6%
282,400
+188.5%
0.01%
+150.0%
Q2 2023$1,847,373
+5498.1%
97,900
+618.1%
0.00%
Q3 2019$33,000
+10.0%
13,6330.0%0.00%
Q2 2019$30,000
-81.5%
13,633
-77.3%
0.00%
Q1 2019$162,000
-47.1%
59,951
-6.1%
0.00%
-100.0%
Q4 2018$306,000
-49.3%
63,8330.0%0.00%0.0%
Q3 2018$604,000
-14.2%
63,833
-11.8%
0.00%0.0%
Q2 2018$704,000
+20.3%
72,333
+30.1%
0.00%0.0%
Q1 2018$585,000
+87.5%
55,600
+14.2%
0.00%
Q4 2017$312,000
+9.1%
48,700
+30.2%
0.00%
Q3 2017$286,00037,4000.00%
Other shareholders
IMMUNOGEN INC shareholders Q4 2017
NameSharesValueWeighting ↓
Redmile Group, LLC 13,063,767$35,403,0001.04%
QVT Financial LP 1,375,900$3,442,0000.87%
Virtus ETF Advisers LLC 50,045$136,0000.29%
Fernwood Investment Management, LLC 187,000$507,0000.27%
PURA VIDA INVESTMENTS, LLC 524,600$1,422,0000.20%
Endurant Capital Management LP 184,440$500,0000.20%
Birchview Capital, LP 90,000$244,0000.15%
TWIN FOCUS CAPITAL PARTNERS, LLC 112,873$306,0000.14%
DLD Asset Management, LP 1,239,500$3,347,0000.12%
DLD Asset Management, LP 1,186,300$3,215,0000.12%
View complete list of IMMUNOGEN INC shareholders